Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.
about
Use of Vaxfectin adjuvant with DNA vaccine encoding the measles virus hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques against measles virusPoxvirus orthologous clusters: toward defining the minimum essential poxvirus genomePredominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaquesModified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseasesDifferent patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines.Viral vector-based influenza vaccines.Tropism illuminated: lymphocyte-based pathways blazed by lethal morbillivirus through the host immune systemReplication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.Modified H5 promoter improves stability of insert genes while maintaining immunogenicity during extended passage of genetically engineered MVA vaccinesRecombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus.A chimeric human-bovine parainfluenza virus type 3 expressing measles virus hemagglutinin is attenuated for replication but is still immunogenic in rhesus monkeys.Modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles.Relative contributions of measles virus hemagglutinin- and fusion protein-specific serum antibodies to virus neutralizationImmunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infectionInfluence of maternal antibodies on neonatal immunization against respiratory viruses.Immunization of newborn rhesus macaques with simian immunodeficiency virus (SIV) vaccines prolongs survival after oral challenge with virulent SIVmac251.Expression of CCL20 and granulocyte-macrophage colony-stimulating factor, but not Flt3-L, from modified vaccinia virus ankara enhances antiviral cellular and humoral immune responses.Live-attenuated measles virus vaccine targets dendritic cells and macrophages in muscle of nonhuman primates.Multiple linear epitopes (B-cell, CTL and Th) of JEV expressed in recombinant MVA as multiple epitope vaccine induces a protective immune responseCorrelation of immunogenicities and in vitro expression levels of recombinant modified vaccinia virus Ankara HIV vaccines.Enhanced cell surface expression, immunogenicity and genetic stability resulting from a spontaneous truncation of HIV Env expressed by a recombinant MVA.Dose-dependent protection against or exacerbation of disease by a polylactide glycolide microparticle-adsorbed, alphavirus-based measles virus DNA vaccine in rhesus macaques.Generation of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression.Macaque models of human infectious disease.Elucidating and minimizing the loss by recombinant vaccinia virus of human immunodeficiency virus gene expression resulting from spontaneous mutations and positive selection.Measles vaccination: new strategies and formulations.Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccines.Cidofovir resistance in vaccinia virus is linked to diminished virulence in mice.A ferret model of canine distemper virus virulence and immunosuppression.Identification of a common HLA-DP4-restricted T-cell epitope in the conserved region of the respiratory syncytial virus G proteinAn orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels.MhcDRB-sequences from cynomolgus macaques (Macaca fascicularis) of different origin.In Vitro Measles Virus Infection of Human Lymphocyte Subsets Demonstrates High Susceptibility and Permissiveness of both Naive and Memory B Cells.Effect of maternal HIV infection on measles susceptibility during early infancy: implications for optimizing protection of the infant
P2860
Q24658311-C3F9010C-0784-43DE-ABFD-FDBE774C0E17Q24683201-6F76EFD9-B10C-4A6B-9408-F88F377DB841Q27319538-D27DEA16-FB06-49CA-A921-029DE7D48620Q30209342-6AB48A4D-FA3C-41C0-A77C-AD00C49F6D8AQ30330620-F0E76898-3725-48FF-A57E-FA8B81E8633FQ30390938-25981CFD-AC95-4C69-B903-2D8819200201Q30833740-E2C8BC03-9C8B-4AF7-B18E-E45F8016110DQ33187731-1EFD4D16-A0E0-4881-8341-46411F29B6C8Q33653229-9FF5F5C6-CAD2-4E22-8712-89EE9FB0F9CEQ33834543-3935A5BE-1E73-47D0-B180-95ACD4D861EEQ33843163-3AA43813-E588-4FB4-B6A1-06A6980E9C56Q33848343-692C0DA5-5CDB-4D83-9837-F230841C80F7Q33920185-A786C377-6E08-4E9E-8FC5-4BCABDB60CF6Q33930445-BEB8BB99-4F2E-4D66-ADFB-9DB0D7033CCAQ34355131-49179313-36E3-4045-B1FB-496D53ACA762Q34398563-5C4962B3-2E6D-4AFD-B557-629D7B25EF73Q34462107-9277DBED-484B-447A-BF4E-5B3C570D9A6CQ35023778-95A5D8DE-8E1A-45C7-91DB-4BC4C415F4ADQ35115588-E47202AE-8297-4FE4-928B-A2B6762B2587Q36437384-8F534833-D3BF-481B-9510-C17609DC7ABDQ36488676-543EDDA2-3820-4690-B8B4-4320220645B4Q36532471-27E20897-572A-4072-AD19-B40C070B6371Q36539048-3B1AED65-7413-4B65-B51E-9D986CA78EF4Q37069798-FE6A5F5A-1FBE-455A-B4DB-B2F760167A3EQ37103536-25399696-59A6-4FF3-9DA2-AADC11EB910EQ37248017-06D9796A-C1C4-4131-ADE9-4991B40BCC85Q37290110-ECABE5E3-56E5-4671-A614-70E272EBA124Q37346420-1016BF6D-E30E-49D4-B835-25441D0FC252Q38760673-2D9191E7-9A9A-4F48-847A-BC8ADCC48670Q40173347-31DE45E5-A743-4DBF-90C9-CDBB4A0FEE00Q40594998-B23DD1CC-8413-4324-98FE-B9E9ECDAFB53Q40867301-B30B349B-3E39-44EC-B700-F06BB83428A0Q46860008-6B8BE4EA-A091-4770-85F0-58886816A050Q50043340-D5F2530D-8C67-4A51-B865-8434E6E07DC2Q58052657-0A359D01-1A42-4F68-8516-722B6FC7BBEC
P2860
Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Protective immunity in macaque ...... passively acquired antibodies.
@ast
Protective immunity in macaque ...... passively acquired antibodies.
@en
type
label
Protective immunity in macaque ...... passively acquired antibodies.
@ast
Protective immunity in macaque ...... passively acquired antibodies.
@en
prefLabel
Protective immunity in macaque ...... passively acquired antibodies.
@ast
Protective immunity in macaque ...... passively acquired antibodies.
@en
P2093
P2860
P1433
P1476
Protective immunity in macaque ...... passively acquired antibodies
@en
P2093
A D Osterhaus
G van Amerongen
K J Stittelaar
R S van Binnendijk
S Rozenblatt
P2860
P304
P356
10.1128/JVI.74.9.4236-4243.2000
P577
2000-05-01T00:00:00Z